arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

KalVista Pharmaceuticals, Inc.

KALV Health Care Biotechnology: Pharmaceutical Preparations
$27.00
Today
as of Oct 23, 16:49 ET
Open
$26.99
High
$27.00
Low
$26.98
Volume
$4M
Avg Vol
$4M
Mkt Cap
$1.4B
P/E (TTM)
—
Beta
—
52w High
$27.00
52w Low
$9.83
Div Yield
—
Shares Out
$51M

KALV earnings at a glance

The options market is pricing a move of about ±14.8% after the report, a range of roughly $23.00 to $31.00 from today's $27.00. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±1.6% on average; after the most recent report on May 14, 2026 it moved -0.1%. That means options currently expect more movement than KALV has typically delivered. KALV beat the consensus EPS estimate in 0 of its last 2 reported quarters. Implied volatility is currently 125%. The share price of $27.00 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$9.83
$27
100% of range
Avg surprise (last 2)
-22.4%
Avg reaction (last 2)
-1.6%
0% positive
Latest IV / EM
125%
EM ±14.8% · $25 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.99$-0.83$-0.68$-0.53$-0.37 Actual $-0.87Actual $-0.91Actual $-0.92Actual $-0.98Actual $-0.99Est $-0.77Actual $-0.92Actual $-0.43Est $-0.37 JulOctJanMarApr/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-60M$-41M$-23M$-4M$14M Jan 25Mar 25Jun 25Jul 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.43 $-0.37 -16.2% — -0.1% earnings
Tue Sep 30, 2025Sep 2025 $-0.92 — — — — financials
Thu Jul 10, 2025Apr/2025 $-0.99 $-0.77 -28.6% — -3.0% earnings
Mon Mar 31, 2025Mar 2025 $-0.98 — — — — financials
Fri Jan 31, 2025Jan 2025 $-0.92 — — — — financials
Thu Oct 31, 2024Oct 2024 $-0.91 — — — — financials
Wed Jul 31, 2024Jul 2024 $-0.87 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jul 2025Jun 2025Apr 2025Mar 2025Jan 2025
Revenue——$14M$1M————
Cost of revenue$3M—$1M—————
Gross profit————————
Operating income$-23M—$-46M$-59M——$-50M$-43M
Net income$-23M—$-49M$-60M$-58M—$-52M$-49M
EPS (diluted)$-0.43—$-0.92$-1.12——$-0.98$-0.92

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jul 2025Jun 2025Apr 2025Mar 2025Jan 2025
Cash & equivalents$214M$229M$243M$124M—$132M—$167M
Inventory$4M$3M$458,000—————
Total current assets$314M$320M$325M$206M—$242M—$267M
Total assets$329M$335M$340M$216M—$251M—$276M
Long-term debt$172M———————
Total liabilities$349M$338M$323M—————
Total equity$-20M$-3M$17M$41M$59M$95M$117M$145M

Implied volatility — last 90 days

96%103%110%118%125% Jun 07 — IV 96% · EM ±13.4%Jun 08 — IV 112% · EM ±14.8%Jun 09 — IV 118% · EM ±14.8%Jun 10 — IV 125% · EM ±14.8%

Sector peers

KALV earnings FAQ

What is KALV's expected move for earnings?

Options currently price a move of about ±14.8%, or $4.00 per share either way from $27.00.

How does KALV stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.6%, up 0 times and down 2 times.

What is KALV's implied volatility?

KALV's at-the-money implied volatility is about 125% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.